Incyte Corporation (INCY)
NASDAQ · Health Care · market cap 19.33B
Share price
$127.62
At the last nightly close
Intrinsic value
$70.20
Range $70.20 – $90.36 — the conservative figure is the low end.
Margin of safety
-45.0%
($70.20 − $127.62) ÷ $127.62
EV / EBIT
222.7
On the median operating profit of 15 fiscal years through 2025.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.
The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-04.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 5.14B | 1.34B | 1.29B | 6.59 | 1.33B |
| 2024-FY | 4.24B | 101.3M | 32.6M | 0.16 | 235.2M |
| 2023-FY | 3.70B | 655.4M | 597.6M | 2.67 | 449.0M |
| 2022-FY | 3.39B | 591.6M | 340.7M | 1.53 | 892.1M |
| 2021-FY | 2.99B | 585.8M | 948.6M | 4.27 | 568.5M |
Filed figures from SEC EDGAR, in the reporting currency.
Next earnings
Recent news
- Incyte Stock: New Catalysts Support Another Leg Higher (NASDAQ:INCY) | Seeking Alphaseekingalpha.com
- Incyte (NASDAQ:INCY) Beats Q1 Estimates and Unveils Robust Pipeline Catalysts | ChartMill.comchartmill.com
- Incyte (Nasdaq:INCY) - Stock Analysissimplywall.st
- Incyte (INCY) Earnings: Latest Report, Earnings Call & Financialspublic.com
- Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on INCY.
Run the board on INCY10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.